Valuation: NOVARTIS

Market Cap 267B 237B 221B 201B 380B 25,679B 383B 2,678B 1,038B 13,092B 1,001B 979B 42,073B P/E 2026 *
19.8x
P/E 2027 * 16.6x
Enterprise Value 298B 265B 247B 225B 425B 28,703B 429B 2,993B 1,161B 14,634B 1,119B 1,095B 47,028B EV / Sales 2026 *
5.17x
EV / Sales 2027 * 4.8x
Free-Float
91.66%
Yield 2026 *
3.09%
Yield 2027 * 3.23%
Manager TitleAgeSince
Chief Executive Officer 50 01/02/2018
Director of Finance/CFO - 16/03/2026
Compliance Officer 58 14/04/2025
Director TitleAgeSince
Director/Board Member 67 01/01/2015
Director/Board Member 69 01/01/2016
Director/Board Member 61 01/01/2016
Change 5-day change 1-year change 3-year change Capi.($)
-0.61%-3.43%+36.07%+117.61% 1,019B
-1.02%-5.60%+35.72%+64.82% 617B
+1.11%-0.58%+12.36%+78.27% 464B
+0.34%-3.01%+61.79%+41.79% 356B
-0.95%-4.05%+20.54%+40.33% 333B
-1.46%-2.89%+10.57%+26.54% 267B
-1.35%-5.43%-6.17%+8.82% 244B
-1.04%-2.79%+35.30%+54.42% 218B
-1.87%-4.10%+28.44%+97.54% 179B
Average -0.76%-3.39%+26.07%+58.90% 410.8B
Weighted average by Cap. -0.60%-3.33%+29.07%+71.15%

Financials

2026 *2027 *
Net sales 57.69B 51.24B 47.79B 43.55B 82.21B 5,555B 82.94B 579B 225B 2,832B 217B 212B 9,102B 61.43B 54.57B 50.89B 46.37B 87.55B 5,916B 88.33B 617B 239B 3,016B 231B 226B 9,693B
Net income 14.23B 12.64B 11.79B 10.74B 20.28B 1,370B 20.46B 143B 55.4B 699B 53.42B 52.26B 2,245B 15.79B 14.03B 13.08B 11.92B 22.5B 1,521B 22.7B 159B 61.49B 775B 59.28B 58B 2,492B
Net Debt 31.4B 27.89B 26.01B 23.7B 44.75B 3,024B 45.15B 315B 122B 1,542B 118B 115B 4,955B 28.22B 25.07B 23.38B 21.3B 40.22B 2,718B 40.57B 283B 110B 1,386B 106B 104B 4,453B
Logo NOVARTIS
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (30.9%); - immunology (18.9%); - cardiovascular, renal and metabolic diseases (16.4%); - neuroscience (11%). The remaining net sales (22.8%) are from contract manufacturing of pharmaceutical products. At the end of 2025, Novartis AG had over 31 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (2.6%), Europe (28.1%), the United States (42.8%), Asia/Africa/Australasia (19.8%), Canada and Latin America (6.7%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
AAA